Don't want to trade it yourself?
Our desk runs DEX portfolios on profit share.
35%
Share
$2.5K
Minimum
Crypto asset manager 21Shares filed an amended S-1 registration statement for a spot Injective ETF with the U.S. SEC on Sept. 18, Crypto Briefing reported. If approved, the ETF will trade on Nasdaq under the ticker ‘TINJ,’ track the price of INJ based on the FTSE Injective Index, and include a strategy allowing the issuer to stake a portion of its INJ holdings at its discretion to reflect staking rewards.
The filing does not mean the ETF has been approved for launch, and a final decision will be made after the SEC’s review. According to CoinMarketCap, INJ was trading at $6.59, up 14.98%.